Systematic Review on N-3 and N-6 Polyunsaturated Fatty Acid Intake in European Countries in Light of the Current Recommendations – Focus on Specific Population Groups
Metadatos
Afficher la notice complèteEditorial
Karger
Materia
N-3 polyunsaturated fatty acid N-6 polyunsaturated fatty acid Dietary intake Dietary recommendations
Date
2017-02-11Referencia bibliográfica
Sioen, I., van Lieshout, L., Eilander, A., Fleith, M., Lohner, S., Szommer, A., ... & Campoy, C. (2017). Systematic review on n-3 and n-6 polyunsaturated fatty acid intake in European countries in light of the current recommendations-Focus on specific population groups. Annals of nutrition and metabolism, 70(1), 39-50. [DOI: 10.1159/000456723]
Patrocinador
ILSI Europe Nutrient Intake Optimisation Task Force; Early Nutrition and Long-Term Health Task ForceRésumé
Background: Earlier reviews indicated that in many countries
adults, children and adolescents consume on an average
less polyunsaturated fatty acids (PUFAs) than recommended
by the Food and Agriculture Organisation/World
Health Organisation. Summary: The intake of total and individual
n-3 and n-6 PUFAs in European infants, children, adolescents,
elderly and pregnant/lactating women was evaluated
systematically. Results: The evaluations were done
against recommendations of the European Food Safety
Authority. Key Messages: Fifty-three studies from 17 different
European countries reported an intake of total n-3 and n-6 PUFAs and/or individual n-3 or n-6 PUFAs in at least one
of the specific population groups: 10 in pregnant women,
4 in lactating women, 3 in infants 6–12 months, 6 in children
1–3 years, 11 in children 4–9 years, 8 in adolescents 10–18
years and 11 in elderly >65 years. Mean linoleic acid intake
was within the recommendation (4 energy percentage [E%])
in 52% of the countries, with inadequate intakes more likely
in lactating women, adolescents and elderly. Mean α-linolenic
acid intake was within the recommendation (0.5 E%) in 77%
of the countries. In 26% of the countries, mean eicosapentaenoic
acid and/or docosahexaenoic acid intake was as recommended.
These results indicate that intake of n-3 and n-6
PUFAs may be suboptimal in specific population groups in
Europe.